Adult; COVID-19/epidemiology; Clinical Trials as Topic; Europe/epidemiology; Female; Geography; Humans; Interdisciplinary Communication; Internet; Latin America/epidemiology; Male; Medical Oncology/trends; Middle Aged; Neoplasms/therapy; Palliative Care/organization & administration; Pandemics; Registries; Surveys and Questionnaires; Telemedicine; United States/epidemiology
Abstract :
[en] PURPOSE: The COVID-19 pandemic has affected healthcare systems globally, leading to reorganization of medical activities. We performed an international survey aimed to investigate the medium- and long-term impact on oncology units. MATERIALS AND METHODS: An 82-item survey was distributed from June 17 to July 14, 2020 among medical oncologists worldwide. RESULTS: One hundred nine medical oncologists from 18 countries in Europe (n = 93), United States (n = 5), and Latin America (n = 11) answered the survey. A systematic tracing of COVID-19-positive patients was continued in the postacute phase by 77.1% of the centers; 64.2% of the respondents participated in a local registry and 56% in international or national registries of infected patients. Treatment adaptations were introduced, and surgery was the most affected modality being delayed or canceled in more than 10% of patients in 34% of the centers, whereas early cessation of palliative treatment was reported in 32.1% of the centers; 64.2% of respondents reported paying attention to avoid undertreatments. The use of telemedicine has been largely increased. Similarly, virtual tools are increasingly used particularly for medical education and international or national or multidisciplinary meetings. 60.6% of the participants reduced clinical activity, and 28.4% compensated by increasing their research activity. Significant reduction of clinical trial activities is expected in 37% of centers this year. The well-being of healthcare staff would not recover by the end of the year according to 18% of the participants. CONCLUSION: The COVID-19 outbreak has had a major impact on oncologic activity, which will persist in the future, irrespective of geographical areas.
Disciplines :
Oncology
Author, co-author :
ONESTI, Concetta Elisa ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service d'oncologie médicale
Tagliamento, Marco
Curigliano, Giuseppe
Harbeck, Nadia
Bartsch, Rupert
Wildiers, Hans
Tjan-Heijnen, Vivianne
Martin, Miguel
Rottey, Sylvie
Generali, Daniele
Campone, Mario
Cristofanilli, Massimo
Pusztai, Lajos
Peeters, Marc
Berchem, Guy
Cortes, Javier
Ruhstaller, Thomas
Ciruelos, Eva
Rugo, Hope S.
Jerusalem, Guy ; Université de Liège - ULiège > Département des sciences cliniques > Oncologie
Zhu N, Zhang D, Wang W, et al: A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727-733, 2020.
WHO Director-General's opening remarks at the media briefing on COVID-19-March 11, 2020. https://www.who.int/dg/speeches/detail/who-director-generals-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020
Ackermann M, Verleden SE, Kuehnel M, et al: Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 383:120-128, 2020 4. Mehta P, McAuley DF, Brown M, et al: COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet 395:1033-1034, 2020
Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19). https://www.who.int/docs/default-source/coronaviruse/who-china-jointmission-on-covid-19-final-report.pdf
Liang W, Guan W, Chen R, et al: Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China. Lancet Oncol 21:335-337, 2020
Miyashita H, Mikami T, Chopra N, et al: Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City. Ann Oncol 31:1088-1089, 2020
Dai M, Liu D, Liu M, et al: Patients with cancer appear more vulnerable to SARS-CoV-2: A multicenter study during the COVID-19 outbreak. Cancer Discov 10:783-791, 2020
Kuderer NM, Choueiri TK, Shah DP, et al: Clinical impact of COVID-19 on patients with cancer (CCC19): A cohort study. Lancet 395:1907-1918, 2020
Lee LYW, Cazier JB, Starkey T, et al: COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: A prospective cohort study. Lancet Oncol 21:1309-1316, 2020
Garassino MC, Whisenant JG, Huang LC, et al: COVID-19 in patients with thoracic malignancies (TERAVOLT): First results of an international, registry-based, cohort study. Lancet Oncol 21:914-922, 2020
Onesti CE, Rugo HS, Generali D, et al: Oncological care organisation during COVID-19 outbreak. ESMO Open 5:e000853, 2020
Saini KS, Tagliamento M, Lambertini M, et al: Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies. Eur J Cancer 139:43-50, 2020
Curigliano G, Banerjee S, Cervantes A, et al: Managing cancer patients during the COVID-19 pandemic: An ESMO multidisciplinary expert consensus. Ann Oncol 31:1320-1335, 2020
Poggio F, Tagliamento M, Di Maio M, et al: Assessing the impact of the COVID-19 outbreak on the attitudes and practice of Italian oncologists toward breast cancer care and related research activities. JCO Oncol Pract 16:e1304-e1314, 2020
Luo M, Guo L, Yu M, et al: The psychological and mental impact of coronavirus disease 2019 (COVID-19) on medical staff and general public-A systematic review and meta-analysis. Psychiatry Res 291:113190, 2020
Onesti CE, Schroeder H, Rorive A, et al: 1720P how do oncological patients perceive the COVID-19 pandemic? Experience from CHU Liège in Belgium. Ann Oncol 31:S1010, 2020
United Nations. Population Division. Department of Economics and Social Affairs: World Population Prospects 2019. New York, NY, United Nations, 2019
COVID-19 data repository by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. https://github.com/CSSEGISandData/ COVID-19
Tagliamento M, Spagnolo F, Poggio F, et al: Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak. Eur J Clin Invest 50:e13315, 2020
Ürün Y, Hussain SA, Bakouny Z, et al: Survey of the impact of COVID-19 on oncologists' decision making in cancer. JCO Glob Oncol 6:1248-1257, 2020
Dinmohamed AG, Visser O, Verhoeven RHA, et al: Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. Lancet Oncol 21:750-751, 2020
COVID-19 Delays Cancer Screenings. Cancer Discov 10:OF4, 2020
Maringe C, Spicer J, Morris M, et al: The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: A national, population-based, modelling study. Lancet Oncol 21:1023-1034, 2020
Sharpless NE: COVID-19 and cancer. Science 368:1290, 2020
Brar G, Pinheiro LC, Shusterman M, et al: COVID-19 severity and outcomes in patients with cancer: A matched cohort study. J Clin Oncol 38:3914-3924, 2020
Sud A, Jones ME, Broggio J, et al: Collateral damage: The impact on outcomes from cancer surgery of the COVID-19 pandemic. Ann Oncol 31:1065-1074, 2020
Fligor SC, Wang S, Allar BG, et al: Gastrointestinal malignancies and the COVID-19 pandemic: Evidence-based triage to surgery. J Gastrointest Surg 24:2357-2373, 2020
Ginsburg KB, Curtis GL, Timar RE, et al: Delayed radical prostatectomy is not associated with adverse oncologic outcomes: Implications for men experiencing surgical delay due to the COVID-19 pandemic. J Urol 204:720-725, 2020
Dowsett M, Ellis MJ, Dixon JM, et al: Evidence-based guidelines for managing patients with primary ER+ HER2- breast cancer deferred from surgery due to the COVID-19 pandemic. NPJ Breast Cancer 6:21, 2020
Lang FM, Lee KM, Teijaro JR, et al: GM-CSF-based treatments in COVID-19: Reconciling opposing therapeutic approaches. Nat Rev Immunol 20:507-514, 2020